When diet is not enough - obesity treatment options
DOI:
https://doi.org/10.12775/JEHS.2023.42.01.002Keywords
obesity treatment, bariatric surgery, liraglutide, orlistatAbstract
Introduction: Obesity and overweight are common diseases affecting both children and adults. They cause a number of health consequences, both physical and mental. The diseases underlying obesity include hypertension, type II diabetes and selected cancers. The etiology is multifactorial, resulting from environmental, behavioral and genetic factors.
Aim of the study: The aim of our study is to summarize the therapeutic options available to overweight and obese people. We paid special attention to the available pharmacology and surgical treatment. We compared these methods in terms of effectiveness, possible complications and side effects.
Materials and methods: The literature available in the PubMed and Google Scholar databases was reviewed, using the following keywords: "obesity treatment", "obesity pharmacotherapy", "bariatric surgery".
Conclusions: There are many treatment options for people who have not improved with diet and increased physical activity alone. The availability of both pharmacotherapy and bariatric surgery enables effective treatment of obesity and overweight tailored to the needs of patients.
References
Por. komunikaty CBOS: „Czy Polacy mają problem z nadwagą? ”, sierpień 2019 (oprac. M. Rutkowska);
WHO European Childhood Obesity Surveillance Initiative (COSI) Report on the fourth round of data collection, 2015-2017. (n.d.). (dostęp: 12.05.23 r.), from https://apps.who.int/iris/bitstream/handle/10665/341189/ WHO-EURO-2021-2495-42251-58349-eng.pdf?sequence=1&isAllowed=y
Jung, U., & Choi, M.-S. (2014). Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences, 15(4), 6184–6223. https://doi.org/10.3390/ijms15046184
Swinburn, B. A., Sacks, G., Hall, K. D., McPherson, K., Finegood, D. T., Moodie, M. L., & Gortmaker, S. L. (2011). The global obesity pandemic: shaped by global drivers and local environments. The Lancet, 378(9793), 804–814. https://doi.org/10.1016/s0140-6736(11)60813-1
Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., Michos, E. D., Miedema, M. D., Muñoz, D., Smith, S. C., Virani, S. S., Williams, K. A., Yeboah, J., & Ziaeian, B. (2019). 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary. Circulation, 140(11). https://doi.org/10.1161/cir. 0000000000000677
Reimisz, P. (2022). Leczenie otyłości. Dlaczego „silna wola” to za mało? Część I: Przyczyny otyłości. Kosmos, 71(2), 93–104. https://doi.org/10.36921/kos.2022_2859
Buoncristiano, M., Spinelli, A., Williams, J., Nardone, P., Rito, A. I., García‐Solano, M., Grøholt, E. K., Gutiérrez‐González, E., Klepp, K. I., Starc, G., Petrauskienė, A., Kunešová, M., Hassapidou, M., Pérez‐Farinós, N., Pudule, I., Kelleher, C. C., Duleva, V., Rakovac, I., Chatterjee, S., & Breda, J. (2021). Childhood overweight and obesity in Europe: Changes from 2007 to 2017. Obesity Reviews, 22(S6). https://doi.org/10.1111/ obr.13226
Kłósek, P. (2016). Zależności między stresem psychologicznym a powstawaniem otyłości. Forum Medycyny Rodzinnej, 10(3), 145–152. https://journals.viamedica.pl/forum_medycyny_rodzinnej/article/view/ 48301/35551
Corrigendum. (2015). The Journal of Clinical Endocrinology & Metabolism, 100(5), 2135–2136. https://doi.org/10.1210/jc.2015-1782
Orsolini, Laura, et al. “The “Collateral Side” of Mood Stabilizers: Safety and Evidence-Based Strategies for Managing Side Effects.” Expert Opinion on Drug Safety, vol. 19, no. 11, 5 Sept. 2020, https://doi.org/ 10.1080/14740338.2020.1820984. Accessed 16 Sept. 2020.
Davies, Melanie J., et al. “Efficacy of Liraglutide for Weight Loss among Patients with Type 2 Diabetes.” Jama, vol. 314, no. 7, 18 Aug. 2015, p. 687, https://doi.org/10.1001/jama.2015.9676. Accessed 27 Nov. 2019.
Siniarski, A., & Gajos, G. (2022). Leczenie otyłości a choroby układu sercowo-naczyniowego — gdziej jesteśmy i dokąd zmierzamy? Choroby Serca I Naczyń, 18(4), 171–182. https://doi.org/10.5603/chsin. 2021.0019
Greenway, F. L., Fujioka, K., Plodkowski, R. A., Mudaliar, S., Guttadauria, M., Erickson, J., Kim, D. D., & Dunayevich, E. (2010). Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet, 376(9741), 595–605. https://doi.org/10.1016/s0140-6736(10)60888-4
Mapa Statystyk NFZ: http://www.sga.waw.pl/web/mapNFZ/index.html? w=0&z=0&o=0&j=262&k=1&y1=2018&y2=2019 (dostęp: 12.05.23 r.)
Miras, A. D., & le Roux, C. W. (2013). Mechanisms underlying weight loss after bariatric surgery. Nature Reviews Gastroenterology & Hepatology, 10(10), 575–584. https://doi.org/10.1038/nrgastro.2013.119
, Sjöström, L. (2013). Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery. Journal of Internal Medicine, 273(3), 219–234. https:// doi.org/10.1111/joim.12012
, Anselmino, M., Bammer, T., Fernández Cebrián, J. M., Daoud, F., Romagnoli, G., & Torres, A. (2009). Cost-effectiveness and Budget Impact of Obesity Surgery in Patients with Type 2 Diabetes in Three European Countries(II). Obesity Surgery, 19(11), 1542–1549. https://doi.org/10.1007/s11695-009-9946-z
Buchwald, H., Estok, R., Fahrbach, K., Banel, D., Jensen, M. D., Pories, W. J., Bantle, J. P., & Sledge, I. (2009). Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis. The American Journal of Medicine, 122(3), 248-256.e5. https://doi.org/10.1016/j.amjmed.2008.09.041
Schauer, D. P., Feigelson, H. S., Koebnick, C., Caan, B., Weinmann, S., Leonard, A. C., Powers, J. D., Yenumula, P. R., & Arterburn, D. E. (2017). Association Between Weight Loss and the Risk of Cancer after Bariatric Surgery. Obesity, 25, S52–S57. https://doi.org/10.1002/oby.22002
Sarwer, D. B., Lavery, M., & Spitzer, J. C. (2012). A Review of the Relationships Between Extreme Obesity, Quality of Life, and Sexual Function. Obesity Surgery, 22(4), 668–676. https://doi.org/10.1007/ s11695-012-0588-1
Sullivan, M., Karlsson, J., Sjöström, L., Backman, L., Bengtsson, C., Bouchard, C., Dahlgren, S., Jonsson, E., Larsson, B., & Lindstedt, S. (1993). Swedish obese subjects (SOS)--an intervention study of obesity. Baseline evaluation of health and psychosocial functioning in the first 1743 subjects examined. International Journal of Obesity and Related Metabolic Disorders, 17(9), 503–512. https://europepmc.org/article/med/ 8220652
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Marika Polatowska, Zuzanna Czudy, Hanna Dominik, Wojciech Pawęska, Jan Radwański, Anna Gadomska, Justyna Kurek, Rafał Gorzyński, Michał Garstka, Justyna Molczyk-Sieńczak
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 947
Number of citations: 0
